Search | IOVS | ARVO Journals

Showing 1 – 20 of 39

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Establishing the optimal cutoff point of near visual acuity for detecting early presbyopia

Kazuno Negishi; Akiko Hanyuda; Miyuki Kubota; Shunsuke Kubota; Sachiko Masui; Kenya Yuki; Masahiko Ayaki

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6305.

ARVO Annual Meeting Abstract July 2019

Pupil Diameter Difference (PDD) During Accommodation is The Important Factor for Presbyopia.

Miyuki Kubota; Shunsuke Kubota; Kazuno Negishi; Kazuo Tsubota

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1801.

ARVO Annual Meeting Abstract July 2018

Long-term results of photodynamic therapy for circumscribed choroidal hemangioma

Yuko Hayashi; Masayasu Kitahashi; Takayuki Baba; Tomohiro Nizawa; Mariko Kubota; Shuichi Yamamoto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5592.

ARVO Annual Meeting Abstract September 2016

The nicotinamide phosphoribosyltransferase (NAMPT)-mediated NAD + biosynthetic pathway is essential for photoreceptor survival and vision

Jonathan B Lin; Shunsuke Kubota; Norimitsu Ban; Mitsukuni Yoshida; Andrea Santeford; Abdoulaye Sene; Miyuki Kubota; Kazuo Tsubota; Jun Yoshino; Shin-ichiro Imai; Rajendra S Apte

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2264.

ARVO Annual Meeting Abstract September 2016

One year outcomes of intravitreal aflibercept for wet AMD using modified treat and extend regimen

Tomohiro Nizawa; Masayasu Kitahashi; Hirotaka Yokouchi; Mariko Kubota; Takayuki Baba; Shuichi Yamamoto

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2669.

Anatomy and Pathology/Oncology June 2016

Expression Profiling of Ascorbic Acid–Related Transporters in Human and Mouse Eyes

PDF

Nan Ma; Carla Siegfried; Miyuki Kubota; Jie Huang; Ying Liu; Margaret Liu; Belinda Dana; Andrew Huang; David Beebe; Hong Yan; Ying-Bo Shui
TAGS: ascorbic acid, eye, membrane transport proteins, mice, adams-stokes syndrome, aspirin, atrial septal aneurysm, gene expression profiling, molecular profiling, rna, messenger
Invest. Ophthalmol. Vis. Sci.. 2016; 57(7):3440-3450. https://doi.org/10.1167/iovs.16-19162

Includes: Supplemental Content

ARVO Annual Meeting Abstract April 2014

Two-year Outcome of Half-time Reduced Fluence Photodynamic Therapy Combined with Intravitreal Ranibizumab for Retinal Angiomatous Proliferation

Akihiro Chiba; Hirotaka Yokouchi; Masayasu Kitahashi; Mariko Kubota; Takayuki Baba; Shuichi Yamamoto

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4943.

ARVO Annual Meeting Abstract April 2014

Oxygen Metabolism in Primary Human Lens Epithelial Cells; Association with Age, Diabetes and Glaucoma

Miyuki Kubota; Carla J Siegfried; Ying-Bo Shui; Fang Bai; Andrew J W Huang; David C Beebe; Beebe laboratory

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6025.

ARVO Annual Meeting Abstract April 2014

Retinal Sensitivity Changes After Half-time Reduced-Fluence Photodynamic Therapy for Central Serous Chorioretinopathy

Hirotaka Yokouchi; Masayasu Kitahashi; Mariko Kubota; Takayuki Baba; Shuichi Yamamoto

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6375.

ARVO Annual Meeting Abstract June 2013

Oxygen Metabolism in Primary Human Lens Epithelial Cells

Miyuki Kubota; Carla Siegfried; Ying-Bo Shui; Fang Bai; Andrew Huang; David Beebe; Beebe Lab

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5749.

ARVO Annual Meeting Abstract June 2013

Long-term Results of Combination Therapy with Half-time Reduced Fluence Photodynamic Therapy and Intravitreal Ranibizumab for Retinal Angiomatous Proliferation

Hirotaka Yokouchi; Masayasu Kitahashi; Madoka Sakurai; Mariko Kubota-Taniai; Takayuki Baba; Shuichi Yamamoto

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3792.

ARVO Annual Meeting Abstract June 2013

Level of vascular endothelial growth factor 165b in human aqueous humor

Takayuki Baba; Guzel Bikbova; Masayasu Kitahashi; Hirotaka Yokouchi; Madoka Sakurai; Mariko Kubota-Taniai; Shuichi Yamamoto

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4121.

ARVO Annual Meeting Abstract June 2013

One-year Results of Intravitreal Ranibizumab Combined with Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

daisuke yamanouchi; Madoka Sakurai; Takayuki Baba; Masayasu Kitahashi; Hirotaka Yokouchi; Mariko Kubota-Taniai; Shuichi Yamamoto

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4626.

ARVO Annual Meeting Abstract March 2012

Short-term Outcome of Combined Reduced Fluence Photodynamic Therapy and Intravitreal Ranibizumab for Retinal Angiomatous Proliferation

Fusae Kajita; Masayasu Kitahashi; Madoka Sakurai; Hironori Yokouchi; Mariko Kubota; Takayuki Baba; Shuichi Yamamoto

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5151.

ARVO Annual Meeting Abstract March 2012

Therapeutic Efficacy of Intravitreal Ranibizumab Combined with Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

Madoka Sakurai; Masayasu Kitahashi; Hirotaka Yokouchi; Takayuki Baba; Mariko Kubota-Taniai; Syuichi Yamamoto

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2062.

ARVO Annual Meeting Abstract March 2012

Pneumatic Displacement Combined with Intravitreal Bevacizumab for Massive Submacular Hemorrhage due to Polypoidal Choroidal Vasculopathy

Masayasu Kitahashi; Takayuki Baba; Madoka Sakurai-Yanagihashi; Hirotaka Yokouchi; Mariko Kubota-Taniai; Yoshinori Mitamura; Shuichi Yamamoto

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2064.

ARVO Annual Meeting Abstract April 2011

Inhibition Of Hypoxia Inducible Factor 2 Alpha In Human Corneal Epithelial Cells Delays Cell Cycle At G2 Phase Even Under Normoxia

Hideyuki Miyashita; Miyuki Kubota; Kazuo Tsubota; Shigeto Shimmura

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):282.

ARVO Annual Meeting Abstract April 2011

Hydrogen Rescues Oxidative Stress-induced Angiogenesis In A Mouse Corneal Alkali-burn Model

Miyuki Kubota; Shunsuke Kubota; Hideyuki Miyashita; Tomohiko Usui; Kazuo Tsubota; Shigeto Shimmura

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6404.

ARVO Annual Meeting Abstract April 2011

The Role Of P38 Mapk Phosphorylated Activation By Reactive Oxygen Species In Corneal Epithelial Cells

Naoko Kato; Miyuki Kubota; Hideyuki Miyashita; Tetsuya Kawakita; Satoru Yoshida; Kazuo Tsubota; Shigeto Shimmura

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4793.

ARVO Annual Meeting Abstract April 2011

Two-year Follow-up Of Subfoveal Pigment Epithelial Detachment In Eyes With Age-related Macular Degeneration And Visual Acuity Better Than 20/40

Takayuki Baba; Masayasu Kitahashi; Mariko Kubota-Taniai; Emi Ohoka; Shuichi Yamamoto

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1679.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Establishing the optimal cutoff point of near visual acuity for detecting early presbyopia

Pupil Diameter Difference (PDD) During Accommodation is The Important Factor for Presbyopia.

Long-term results of photodynamic therapy for circumscribed choroidal hemangioma

The nicotinamide phosphoribosyltransferase (NAMPT)-mediated NAD + biosynthetic pathway is essential for photoreceptor survival and vision

One year outcomes of intravitreal aflibercept for wet AMD using modified treat and extend regimen

Expression Profiling of Ascorbic Acid–Related Transporters in Human and Mouse Eyes

Two-year Outcome of Half-time Reduced Fluence Photodynamic Therapy Combined with Intravitreal Ranibizumab for Retinal Angiomatous Proliferation

Oxygen Metabolism in Primary Human Lens Epithelial Cells; Association with Age, Diabetes and Glaucoma

Retinal Sensitivity Changes After Half-time Reduced-Fluence Photodynamic Therapy for Central Serous Chorioretinopathy

Oxygen Metabolism in Primary Human Lens Epithelial Cells

Long-term Results of Combination Therapy with Half-time Reduced Fluence Photodynamic Therapy and Intravitreal Ranibizumab for Retinal Angiomatous Proliferation

Level of vascular endothelial growth factor 165b in human aqueous humor

One-year Results of Intravitreal Ranibizumab Combined with Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

Short-term Outcome of Combined Reduced Fluence Photodynamic Therapy and Intravitreal Ranibizumab for Retinal Angiomatous Proliferation

Therapeutic Efficacy of Intravitreal Ranibizumab Combined with Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

Pneumatic Displacement Combined with Intravitreal Bevacizumab for Massive Submacular Hemorrhage due to Polypoidal Choroidal Vasculopathy

Inhibition Of Hypoxia Inducible Factor 2 Alpha In Human Corneal Epithelial Cells Delays Cell Cycle At G2 Phase Even Under Normoxia

Hydrogen Rescues Oxidative Stress-induced Angiogenesis In A Mouse Corneal Alkali-burn Model

The Role Of P38 Mapk Phosphorylated Activation By Reactive Oxygen Species In Corneal Epithelial Cells

Two-year Follow-up Of Subfoveal Pigment Epithelial Detachment In Eyes With Age-related Macular Degeneration And Visual Acuity Better Than 20/40

To View More...

You must be signed into an individual account to use this feature.